Page 27 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine 68 Ga-PSMA PET CT/MRI in prostate cancer

doi: 10.5534/wjmh.180124 of newly diagnosed prostate cancer: A systematic review of
the literature. Eur Urol Oncol. 2021;4(3):370-395.
19. Jiao J, Zhang J, Li Z, et al. Prostate specific membrane
antigen positron emission tomography in primary prostate doi: 10.1016/j.euo.2020.11.002
cancer diagnosis: First-line imaging is afoot. Cancer Lett. 25. Woo S, Ghafoor S, Becker AS, et al. Prostate-specific
2022;548:215883.
membrane antigen positron emission tomography
doi: 10.1016/j.canlet.2022.215883 (PSMA-PET) for local staging of prostate cancer: A
systematic review and meta-analysis. Eur J Hybrid Imaging.
20. Pepe P, Pepe L, Tamburo M, et al. 68Ga-PSMA PET/CT and
prostate cancer diagnosis: which SUVmax value? In Vivo. 2020;4(1):16.
2023;37(3):1318-1322. doi: 10.1186/s41824-020-00085-9
doi: 10.21873/invivo.13211 26. Hernes E, Revheim ME, Hole KH, et al. Prostate-specific
membrane antigen PET for assessment of primary and
21. Hu X, Wu Y, Yang P, et al. Performance of 68Ga-labeled
prostate-specific membrane antigen ligand positron recurrent prostate cancer with histopathology as reference
emission tomography/computed tomography in the standard: A systematic review and meta-analysis. PET Clin.
diagnosis of primary prostate cancer: A systematic review 2021;16(2):147-165.
and meta-analysis. Int Braz J Urol. 2022;48(6):891-902. doi: 10.1016/j.cpet.2021.03.001
doi: 10.1590/S1677-5538.IBJU.2020.0986 27. Petersen LJ, Zacho HD. PSMA PET for primary lymph node
staging of intermediate and high-risk prostate cancer: An
22. Morigi JJ, Anderson J, DE Nunzio C, et al. Prostate specific
membrane antigen positron emission tomography/ expedited systematic review. Cancer Imaging. 2020;20(1):10.
computed tomography and staging high risk prostate cancer: doi: 10.1186/s40644-020-0290-9
A non-systematic review of high clinical impact literature. 28. Tu X, Zhang C, Liu Z, et al. The role of 68Ga-PSMA positron
Minerva Urol Nephrol. 2021;73(1):32-41.
emission tomography/computerized tomography for
doi: 10.23736/S2724-6051.20.03739-X preoperative lymph node staging in intermediate/high risk
patients with prostate cancer: A diagnostic meta-analysis.
23. Ling SW, De Jong AC, Schoots IG, et al. Comparison of
68Ga-labeled prostate-specific membrane antigen ligand Front Oncol. 2020;10:1365.
positron emission tomography/magnetic resonance imaging doi: 10.3389/fonc.2020.01365
and positron emission tomography/computed tomography 29. Dhar A, Cendejas-Gomez JJ, Castro Mendez L, et al. Using
for primary staging of prostate cancer: A systematic review multiparametric magnetic resonance imaging and prostate
and meta-analysis. Eur Urol Open Sci. 2021;33:61-71.
specific membrane antigen positron emission tomography
doi: 10.1016/j.euros.2021.09.006 to detect and delineate the gross tumour volume of
intraprostatic lesions-a systematic review and meta-analysis.
24. Abrams-Pompe RS, Fanti S, Schoots IG, et al. The role
of magnetic resonance imaging and positron emission Radiother Oncol. 2024;192:110070.
tomography/computed tomography in the primary staging doi: 10.1016/j.radonc.2023.110070

Volume 2 Issue 4 (2024) 8 doi: 10.36922/arnm.4590